Rare diseases
Investigational molecules
Locations
Back to Germany1 444 clinical trials in Hochheim Am Main, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
GermanyStudy on the Safety and Tolerability of Lasmiditan for Treating Migraine in Children Aged 6 to 17
GermanyStudy on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease
GermanyStudy on Long-Term Safety of Pelacarsen for Patients with Cardiovascular Disease Who Completed the Frontiers Apheresis Study
GermanyStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol on Exercise in Patients with Chronic Obstructive Pulmonary Disease (COPD)
GermanyStudy of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer
GermanyStudy Comparing Tacrolimus Formulations for Preventing Kidney Transplant Rejection in Adults
GermanyStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
GermanyGermanyStudy Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma
GermanyStudy on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Gaucher disease and Niemann-Pick disease, exploring new therapeutic approaches for these challenging genetic conditions. Studies aim to evaluate novel treatments for improving neurological symptoms and overall patient outcomes.
Clinical investigations evaluating venglustat and nizubaglustat's effectiveness in managing disease progression.
Research centered on treating Mucopolysaccharidosis Type II (Hunter Syndrome) and Pompe disease, with multiple studies investigating innovative enzyme replacement therapies and novel drug combinations.
Evaluation of treatments like JR-141 and cipaglucosidase alfa for improved patient outcomes.
Studies focused on preventing respiratory syncytial virus infections in older adults, with particular attention to vaccine development and immune response assessment.
Investigation of revaccination strategies and long-term protection against respiratory infections.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
